Abstract
This was a retrospective study to examine the efficacy, practicability and medical safety of a combination of tiapride and unretarded (fast acting formula) carbamazepine in the treatment of alcohol withdrawal syndrome. In five hospitals using this combination for treatment of alcohol withdrawal, 540 patients who had been treated with this combination were identified. An intensive evaluation of patients files and charts was performed. Details of alcohol history and comorbid disorders were extracted from patient files. Severity of alcohol withdrawal had been assessed using the CIWA-A-Score. Gender differences and differences between patients in their first and at least second withdrawal were computed by means of variance analyses (GLM). At baseline (day 1) mean dosage given was 796 for tiapride and 543 mg for carbamazepine. A pooled analysis of the results showed that, in general, medication was well tolerated. Withdrawal symptomatology as indicated by CIWA-A scores clearly decreased over time. Although a significant number of patients had a history of alcohol withdrawal delirium (103) and epileptic seizures (151), few patients suffered from them during treatment (8 and 5, respectively). Only 24 (4.4%) patients dropped out because of lack of efficacy or change of medication, 15 (2.8%) because of side effects. No case of malignant neuroleptic syndrome was recorded. Data analysis showed gender differences and differences between patients in their first and at least second withdrawal for side effects, complications, and in some CIWA-A-scores. In general, severe complications of withdrawal syndrome were more frequent in men compared to women and in patients with repeated inpatient treatment. In line with previous research, the results from this study give further evidence that a combination of the anticonvulsant carbamazepine and tiapride is an effective and safe treatment for alcohol withdrawal treatment.
Similar content being viewed by others
References
Glue P, Nutt D (1990) Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal. Br J Psychiat 157:491–499
Mayo-Smith MF for the American Society of Addiction Medicine, Working Group on Pharmacological Management of Alcohol Withdrawal (1997) Pharmacological management of Alcohol withdrawal. A meta-analysis and evidence-based practice guideline. JAMA 278:144–151
Mariani JJ, Levin FR (2004) Pharmacotherapy for alcohol-related disorders: what clinicians should know. Harv Rev Psychiat 23:351–366
Mayo-Smith MF, Beecher LH, Fischer TL, Gorekick DA, Guillaume JL, Hill A, Jara G, Kasser C, Melbourne J (2004) Management of alcohol withdrawal delirium. An evidence-based guideline. Arch Intern Med 164:1405–1412
Majumdar SK (1990) Chlomethiazole: current status in the treatment of the acute ethanol withdrawal syndrome. Drug Alcohol Depend 27:201–207
Palsson A (1986): The efficacy of early chlormethiazole medication in the prevention of delirium tremens. A retrospective study of the outcome of different drug treatment strategies at the Helsingborg psychiatric clinics, 1975–1980. Acta Psychiatr Scand 73(Suppl. 329):140–145
Lucht M, Kuehn KU, Armbruster J, Abraham G, Gaensicke M, Barnow S, Tretzel H, Freyberger HJ (2003) Alcohol withdrawal treatment in intoxicated vs non-intoxicated patients: a controlled open-label study with tiapride/carbamazepine, clomethiazole and diazepam. Alcohol Alcohol 38:168–175
Baltes I, Gallhofer B, Leising H (1998) Neue Strategien für den akuten Alkoholentzug: Kombination von Carbamazepin und Tiaprid. Psycho 24(Sonderausgabe IV):S199–S203
Gottesleben A, Willemsen D, Wolf C (1995) Retardiertes Carbamazepin in der Therapie des alkoholischen Prädelirs. Akt Neurol 22:60–65
Ritola E, Malinen L (1981) A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiat Scand 64:254–259
Thome J, Wiesbeck GA, Vince GH (1994) Carbamazepin in der Behandlung des Alkoholentzugssyndroms – Eine Übersicht zum aktuellen Forschungsstand. Fortschr Neurol Psychiat 62:125–133
Johnson BA (2004) An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence. Expert Opin Pharmacother 5:1943–1955
Malcolm R, Myrick H, Brady KT, Ballenger JC (2001) Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict 10(Suppl):16–23
Bjorkquist SE, Isohanni M, Makela R, et al. (1976) Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre double-blind comparison with placebo. Acta Psychiat Scand 53:333–342
Flygenring J, Hansen J, Holst B, Petersen E, Sorensen A (1984) Treatment of alcohol withdrawal symptoms in hospitalized patients. A randomized, double-blind comparison of carbamazepine (Tegretol) and barbital (Diemal). Acta Psychiat Scand 69:398–408
Malcolm R, Ballenger JC, Sturgis ET, Anton RA (1989) Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiat 146:617–621
Stuppaeck C, Pycha R, Miller C, Whitworth A, Oberbauer H, Fleischhacker W (1992) Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study. Alcohol Alcohol 27:153–158
Seifert J, Peters E, Kahn K, Metzner C, Ohlmeier M, Te Wildt B, Emrich HM, Schneider U (2004) Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance – a pilot study. Addict Biol 9:43–51
Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC (2002) The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med 17:349–355
Williams D, BcBride AJ (1998) The drug treatment of alcohol withdrawal symptoms: a systematic review. Alcohol Alcohol 33:103–115
Scatton B, Cohen C, Perrault G, Oblin A, Claustre Y, Schoemaker H, Sanger DJ, Rouquier L, Porsolt R (2001) The preclinical pharmacologic profile of tiapride. Eur Psychiat 16:29s–34s
Allain H, Dauzenberg PH, Maurer K, Schuck S, Bonhomme D, Gerard D (2000) Double blind study of tiapride versus haloperidol and placebo agitation and aggressiveness in elderly patients with cognitive impairment. Psychopharmacology 148:361–366
Robert PH, Allain H (2001) Clinical management of agitation in the elderly with tiapride. Eur Psychiat 16:42s–47s
Peters DH, Faulds D (1994) Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome. Drugs 47:1010–1032
Agricola R, Mazzarino M, Urani R (1982) Treatment of acute alcohol withdrawal syndrome with carbamazepine: a double blind comparison with tiapride. J Intern Med Res 10:160–165
Lepola U, Kokko S, Nuutila J, Gordin A (1984) Tiapride and chlordiazepoxide in acute alcohol withdrawal. A controlled clinical trial. Int J Clin Pharm Res 5:321–326
Murphy DJ, Shaw GK, Clarke I (1983) Tiapride and chlormethiazole in alcohol withdrawal: a double-blind trial. Alcohol Alcohol 18:227–237
Albani F, Riva R, Baruzzi A (1995) Carbamazepine clinical pharmacology: a review. Pharmacopsychiatry 28:235–244
Soyka M, Morhart-Klute V, Horak M (2002) A combination of carbamazepine/tiapride in outpatient alcohol detoxification. Results from an open clinical study. Eur Arch Psychiat Clin Neurosci 252:197–200
Soyka M, Clausius N, Hohendorf G, Horak M (2004) Outpatient detxofication with carbamazepine and tiapride – medical safety and results of a follow-up study (in German). Suchtmed 6:307–311
Gartenmeier A, Pelzer E, Soyka M (2005) Treatment of alcohol withdrawal syndrome with combined carbamazepine and tiapride in a patient with probable sleep apnoe syndrome. Pharmacopsychiatry 3:96–98
Franz M, Dlabal H, Kunz S, Ulferts J, Gruppe H, Gallhofer B (2001) Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study. Eur Arch Psychiat Clin Neurosci 251:185–192
Jonasch K, Mende M (2004) Treatment of alcohol withdrawal with tiapride (TiapridexR) vs. clomethiazol (DistraneurinR). An open-label trial (in German). Krankenhauspsychiatrie 15:114–116
WHO (1994) Internationale Klassifikation psychischer Störungen ICD-10 Kapitel V (F) Forschungskriterien. Herausgegeben von H Dilling, W Mombour, MH Schmidt, E Schulte-Warkwort. Huber, Bern
Sullivan JT, Sykora K, Schneiderman J, Neranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal scale (CIWA-Ar). Br J Addict 84:1353–1357
Stuppaeck CH, Barnas C, Falk M, Guenther V, Hummer M, Oberbauer H, Pycha R, Whitworth AB, Fleischhacker WW (1994) Assessment of the alcohol withdrawal syndrome-validity and reliability of the translated and modified clinical institute withdrawal assessment for alcohol scale (CIWA-A). Addiction 89:1287–1292
Microsoft Cooperation (2004) Statistic Package for Social Science software, version 12 (SPSS)
Mueller TI, Stout RL, Rudden S, Brown RA, Gordon A, Dolomon DA, Recupero PR (1997) A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence. Alcohol Clin Exp Res 21:86–92
Soyka M, Schmidt F, Schmidt P (2006) Efficacy and safety of outpatient alcohol detoxification with a combination of Tiapride/Carbamazepine: additional evidence. Pharmaco psychiatry 39:30–34
Shaw GK, Majumdar SK, Waller S, MacGarvie J, Dunn G (1987) Tiapride in the long-term management of alcoholics of anxious or depressive treatment. Br J Psychiat 150:164–168
Shaw GK, Waller S, Majumdar SK, Alberts JL, Latham CJ, Dunn G (1994) Tiapride in the prevention of relapse in recently detoxified alcoholics. Br J Psychiat 165:515–523
Acknowledgement
This study was supported by an unrestricted educational grant by the pharmaceutical company Sanofi-Aventis.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Soyka, M., Schmidt, P., Franz, M. et al. Treatment of alcohol withdrawal syndrome with a combination of tiapride/carbamazepine. Eur Arch Psychiatry Clin Neurosci 256, 395–401 (2006). https://doi.org/10.1007/s00406-006-0644-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-006-0644-8